Nurse-Led Palliative Care Clinical Trial Improves Knowledge and Preparedness in Caregivers of Patients with Idiopathic Pulmonary Fibrosis
- PMID: 34003726
- PMCID: PMC8641836
- DOI: 10.1513/AnnalsATS.202012-1494OC
Nurse-Led Palliative Care Clinical Trial Improves Knowledge and Preparedness in Caregivers of Patients with Idiopathic Pulmonary Fibrosis
Abstract
Rationale: Patients with idiopathic pulmonary fibrosis (IPF) and their caregivers experience stress, symptom burden, poor quality of life, and inadequate preparedness for end-of-life (EOL) care planning as the disease progresses. The hypothesis for this study was that the early introduction of palliative care in the course of IPF would improve knowledge and preparation for EOL, patient-reported outcomes, and advance care planning in patients with IPF and their caregivers. Objectives: We sought to determine the feasibility, acceptability, and efficacy of a nurse-led early palliative care intervention entitled "A Program of SUPPORT" (Symptom management, Understanding the disease, Pulmonary rehabilitation, Palliative care, Oxygen therapy, Research participation, and Transplantation) in patients with IPF and their caregivers. Methods: Patients with IPF (diagnosed in the year previous to their initial center visit) from the University of Pittsburgh Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease at University of Pittsburgh Medical Center-together with their caregivers-were randomized to receive the intervention "A Program of SUPPORT" or usual care. This included a total of three research visits aligned with their clinic visit over a period of 6 to 8 months. We measured feasibility, acceptability, and efficacy of this intervention. Results: A total of 136 patient/caregiver dyads were eligible, and a total of 76 dyads were enrolled and participated. Participants were predominately White males >65 years old. Thirteen percent did not have an identified caregiver. Feasibility was limited; 56% of eligible dyads were enrolled. Eligible dyads (24%) were interested in participating but too fatigued to stay after their clinic visit. There was high attrition (20% of participants died before the study was completed). "A Program of SUPPORT" was acceptable to participants. Efficacy demonstrated a significant improvement in caregiver's knowledge, disease preparedness, and confidence in caring for the patient as well as an improvement in knowledge and advance care planning completion in patient participants. Conclusions: Patients with IPF and their caregivers have unmet needs regarding knowledge of their disease, self-management strategies, and preparedness for EOL planning. This nurse-led intervention demonstrated acceptability and efficacy in knowledge and advance care planning completion in patients and in knowledge, disease preparedness, and confidence in caregivers. Future research should identify additional strategies, including telemedicine resources to reach additional patients and their caregivers earlier in their disease course. Clinical trial registered with clinicaltrials.gov (NCT02929017).
Keywords: caregivers; idiopathic pulmonary fibrosis; nurse-led intervention; palliative care; quality of life.
Figures
Similar articles
-
Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations.BMJ Open Respir Res. 2018 Feb 19;5(1):e000272. doi: 10.1136/bmjresp-2017-000272. eCollection 2018. BMJ Open Respir Res. 2018. PMID: 29531748 Free PMC article.
-
Health Care Costs at the End of Life for Patients with Idiopathic Pulmonary Fibrosis. Evaluation of a Pilot Multidisciplinary Collaborative Interstitial Lung Disease Clinic.Ann Am Thorac Soc. 2020 Jun;17(6):706-713. doi: 10.1513/AnnalsATS.201909-707OC. Ann Am Thorac Soc. 2020. PMID: 32197048
-
Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners.Heart Lung. 2010 Jul-Aug;39(4):304-13. doi: 10.1016/j.hrtlng.2009.08.005. Epub 2009 Nov 20. Heart Lung. 2010. PMID: 20561836 Free PMC article. Clinical Trial.
-
Idiopathic Pulmonary Fibrosis: A Review of Disease, Pharmacological, and Nonpharmacological Strategies With a Focus on Symptoms, Function, and Health-Related Quality of Life.J Pain Symptom Manage. 2020 Jun;59(6):1362-1378. doi: 10.1016/j.jpainsymman.2019.12.364. Epub 2019 Dec 28. J Pain Symptom Manage. 2020. PMID: 31887400 Review.
-
What Patients With Idiopathic Pulmonary Fibrosis and Caregivers Want: Filling the Gaps With Patient Reported Outcomes and Experience Measures.Am J Med. 2020 Mar;133(3):281-289. doi: 10.1016/j.amjmed.2019.08.032. Epub 2019 Sep 11. Am J Med. 2020. PMID: 31520625 Review.
Cited by
-
Effects of Self-Management Interventions in People With Interstitial Lung Disease.Respir Care. 2023 Dec 28;69(1):114-127. doi: 10.4187/respcare.11298. Respir Care. 2023. PMID: 39878768 Free PMC article.
-
Pulmonologists' Perspectives on and Access to Palliative Care for Patients With Idiopathic Pulmonary Fibrosis in South Carolina.Palliat Med Rep. 2023 Oct 30;4(1):292-299. doi: 10.1089/pmr.2023.0038. eCollection 2023. Palliat Med Rep. 2023. PMID: 37915951 Free PMC article.
-
Non-Pharmacological Management of Idiopathic Pulmonary Fibrosis.J Clin Med. 2025 Feb 17;14(4):1317. doi: 10.3390/jcm14041317. J Clin Med. 2025. PMID: 40004847 Free PMC article. Review.
-
A self-management package for pulmonary fibrosis: A feasibility study.PEC Innov. 2024 Aug 5;5:100328. doi: 10.1016/j.pecinn.2024.100328. eCollection 2024 Dec 15. PEC Innov. 2024. PMID: 39247403 Free PMC article.
-
Current Landscape and Future Directions of Patient Education in Adults with Interstitial Lung Disease.ATS Sch. 2023 Oct 18;5(1):184-205. doi: 10.34197/ats-scholar.2023-0069RE. eCollection 2024 Mar. ATS Sch. 2023. PMID: 38633514 Free PMC article. Review.
References
-
- Bajwah S, Higginson IJ, Ross JR, Wells AU, Birring SS, Riley J, et al. The palliative care needs for fibrotic interstitial lung disease: a qualitative study of patients, informal caregivers and health professionals. Palliat Med . 2013;27:869–876. - PubMed
-
- Swigris JJ, Gould MK, Wilson SR. Health-related quality of life among patients with idiopathic pulmonary fibrosis. Chest . 2005;127:284–294. - PubMed
-
- Wijsenbeek M, Kreuter M, Olson A, Fischer A, Bendstrup E, Wells CD, et al. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management. Curr Med Res Opin . 2019;35:2015–2024. - PubMed
-
- Ryerson CJ, Donesky D, Pantilat SZ, Collard HR. Dyspnea in idiopathic pulmonary fibrosis: a systematic review. J Pain Symptom Manage . 2012;43:771–782. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical